Price to Sales ratio Analysis of BlackRock Health Sci TR - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Oct-23
Very Poor PS
27.25
Period Ending - Oct-22
Very Poor PS
-21.29
Growth
228.01 %
Trailing Twelve Months PS
Period Ending - Oct-23
Very Poor PS
14.26
PS Analysis of BlackRock Health Sci TR
| P/S Ratio of BlackRock Health Sci TR with value of 14.26 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of BME rose handsomely by 228.01 % this year. |
| PS Ratio with value of 27.25 was highest in Year Oct-23 in last Five Years. |
| PS Ratio with value of -21.29 was lowest in Year Oct-22 in last Five Years. |
| Latest PS Ratio with value of 27.25 is Greater than Average PS of 4.92 in last five years. |
Other PS Related Info of BME that may interest you.
BlackRock Health Sci TR Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BME | 39.89 | 39.41 | 1.22 % | Asset Management |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| No Significant Value | |
FY - Historical Price to Sales of BlackRock Health Sci TR
| Period | Oct-23 | Oct-22 | Oct-21 | Oct-20 | Oct-19 | Oct-18 | Oct-17 |
|---|---|---|---|---|---|---|---|
| PS | 27.25 | -21.29 | 7.74 | 5.77 | 5.14 | 15.16 | 5.84 |
| Change | 228.01 % | -374.94 % | 34.25 % | 12.20 % | -66.09 % | 159.72 % | -94.33 % |
FY Chart of Price to Sales of BlackRock Health Sci TR
Note : All Data Generated at the End of Trading Hours (EOD Data)